Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: integrated safety analysis from 11 clinical trials of patients with plaque psoriasis

Author	dc.contributor.author	Romiti, R.
Author	dc.contributor.author	Valenzuela F., Manuel A.
Author	dc.contributor.author	Chouela, E. N.
Author	dc.contributor.author	Xu, W.
Author	dc.contributor.author	Pangallo, B.
Author	dc.contributor.author	Moriarty, S. R.
Author	dc.contributor.author	Gürbüz, S.
Author	dc.contributor.author	Riedl, E.
Admission date	dc.date.accessioned	2019-10-15T12:23:50Z
Available date	dc.date.available	2019-10-15T12:23:50Z
Publication date	dc.date.issued	2019
Cita de ítem	dc.identifier.citation	British Journal of Dermatology, Volumen 181, Issue 1, 2019, Pages 202-203
Identifier	dc.identifier.issn	13652133
Identifier	dc.identifier.issn	00070963
Identifier	dc.identifier.other	10.1111/bjd.17604
Identifier	dc.identifier.uri	https://repositorio.uchile.cl/handle/2250/171626
Lenguage	dc.language.iso	en
Publisher	dc.publisher	Blackwell Publishing Ltd
Type of license	dc.rights	Attribution-NonCommercial-NoDerivs 3.0 Chile
Link to License	dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Source	dc.source	British Journal of Dermatology
Keywords	dc.subject	Dermatology
Título	dc.title	Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: integrated safety analysis from 11 clinical trials of patients with plaque psoriasis
Document type	dc.type	Artículo de revista
Cataloguer	uchile.catalogador	SCOPUS
Indexation	uchile.index	Artículo de publicación SCOPUS
uchile.cosecha	uchile.cosecha	SI

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile